Volume 20 No 12 (2022)
 Download PDF
Tasneem A K , Karanki Srinivasu, Mohammad Nezamuddin Khan , S. P. Ahalya, Ahalya S P
Background: Drug Utilization Evaluation studies are crucial to the health care system's efforts to rationalize patient care practices like prescribing, dispensing, and usage of medications. In pharmacoepidemiological studies, DUE plays a crucial role. This study was carried out to assess the prescription and medication use patterns in expectant mothers, comprehend the significance of different classes of drugs used during pregnancy, and categorize them according to US FDA categorization.Methodology: 118 pregnant women's case files were obtained from the medical record department who were admitted in a time span of 3 months, and a retrospective observational study design was chosen to analyze the cases using MS Excel software. Each case file was analyzed for the demographic variables, various categories of drugs prescribed during pregnancy; co-morbidities if present, various drugs under each category; and categorization of prescribed drugs according to US FDA pregnancy category guidelines.Result: The study revealed that the most common co-morbidity was found to be gestational diabetes mellitus, followed by the thyroid. The most commonly prescribed drugs were vitamins and minerals (26.o6%) followed by antibiotics (13.73%). Levocetirizine (35.38%) was the most commonly prescribed anti-histamine. Category B (59.77%) drugs were found to be the most widely prescribed.Conclusion: The present study showed that vitamins and mineral supplements were the most commonly prescribed drugs during pregnancy, while anti-pyretic drugs were used less. Use of category B drugs must be reduced, while category X drugs should be completely avoided. Along with Vitamin D, the use of folic acid should also be increased.
drug utilization evaluation, pregnancy, vitamins, pregnancy drug categories, antibiotics
Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.